126 related articles for article (PubMed ID: 17385307)
1. FDG-PET findings of the brain in lymphomatoid granulomatosis.
Kawai N; Miyake K; Nishiyama Y; Yamamoto Y; Sasakawa Y; Haba R; Kushida Y; Tamiya T; Nagao S
Ann Nucl Med; 2006 Dec; 20(10):683-7. PubMed ID: 17385307
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of [18F]FDG-PET kinetic analysis in non-enhancing primary central nervous system lymphoma: case report.
Kawai N; Kawanishi M; Tamiya T; Nagao S
Ann Nucl Med; 2005 Jul; 19(5):415-9. PubMed ID: 16164200
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of tumor FDG transport and metabolism in primary central nervous system lymphoma using [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) kinetic analysis.
Kawai N; Nishiyama Y; Miyake K; Tamiya T; Nagao S
Ann Nucl Med; 2005 Dec; 19(8):685-90. PubMed ID: 16444994
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of (18)F-FDG PET/CT features and clinical manifestations in one case of subcutaneous lymphomatoid granulomatosis].
Niu JH; Yang H; Zhu CY; Zhang Q; Sun L; Zhu HY; Yao ZL; Yu L; Jing Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):735-41. PubMed ID: 24989286
[TBL] [Abstract][Full Text] [Related]
5. [Lymphomatoid granulomatosis treated with oral cyclophosphamide and prednisolone followed by CHOP].
Kure T; Uozumi K; Kikuchi A; Owatari S; Tsuji T; Haraguchi K; Tokunaga M; Tokunaga M; Suzuki S; Arima T
Nihon Naika Gakkai Zasshi; 2004 Apr; 93(4):774-6. PubMed ID: 15174726
[No Abstract] [Full Text] [Related]
6. [Usefulness of FDG-PET in monitoring effects of the modality therapy for central nervous system malignant lymphoma: report of three cases].
Masada T; Matsumoto Y; Kawai N; Tamiya T; Nagao S
No Shinkei Geka; 2004 Aug; 32(8):859-64. PubMed ID: 15478653
[TBL] [Abstract][Full Text] [Related]
7. A case of central nervous system lymphomatoid granulomatosis; characteristics of PET imaging and pathological findings.
Nishihara H; Nakasato M; Sawa H; Murakami H; Yamamoto D; Moriyama K; Kato N; Hashimoto I; Kamada H; Tanaka S
J Neurooncol; 2009 Jun; 93(2):275-8. PubMed ID: 19104755
[TBL] [Abstract][Full Text] [Related]
8. Case 259: Primary Central Nervous System Lymphomatoid Granulomatosis Mimicking Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS).
Tian D; Zhu X; Xue R; Zhao P; Yao Y
Radiology; 2018 Nov; 289(2):572-577. PubMed ID: 30332362
[TBL] [Abstract][Full Text] [Related]
9. Lymphomatoid granulomatosis treated with rituximab and chemotherapy.
Rao R; Vugman G; Leslie WT; Loew J; Venugopal P
Clin Adv Hematol Oncol; 2003 Nov; 1(11):658-60; discussion 660. PubMed ID: 16258464
[No Abstract] [Full Text] [Related]
10. Failure of CHOP with rituximab for lymphomatoid granulomatosis.
Oosting-Lenstra SF; van Marwijk Kooy M
Neth J Med; 2007 Dec; 65(11):442-7. PubMed ID: 18079567
[TBL] [Abstract][Full Text] [Related]
11. Oral lymphomatoid granulomatosis, the first sign of a 'rare disease': a case report.
Cargini P; Civica M; Sollima L; Di Cola E; Pontecorvi E; Cutilli T
J Med Case Rep; 2014 May; 8():152. PubMed ID: 24886196
[TBL] [Abstract][Full Text] [Related]
12. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
[TBL] [Abstract][Full Text] [Related]
13. Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma.
Moskowitz CH; Schöder H; Teruya-Feldstein J; Sima C; Iasonos A; Portlock CS; Straus D; Noy A; Palomba ML; O'Connor OA; Horwitz S; Weaver SA; Meikle JL; Filippa DA; Caravelli JF; Hamlin PA; Zelenetz AD
J Clin Oncol; 2010 Apr; 28(11):1896-903. PubMed ID: 20212248
[TBL] [Abstract][Full Text] [Related]
14. Brain PET Imaging of 11C-Methionine, 18F-FDG, and 18F-THK5351 in a Case of Lymphomatoid Granulomatosis.
Higashihara M; Ishibashi K; Tokumaru AM; Ishii K; Iwata A
Clin Nucl Med; 2022 Dec; 47(12):e749-e751. PubMed ID: 36342805
[TBL] [Abstract][Full Text] [Related]
15. [Application of 18F-FDG PET for the assessment of early response to the treatment and prognosis of patients].
Oriuchi N; Higuchi T; Endo K; Tsukamoto N; Matsuda H; Kuji I; Murakami K; Nakajima K
Kaku Igaku; 2009 Jun; 46(2):96-9. PubMed ID: 19637820
[TBL] [Abstract][Full Text] [Related]
16. Grade I lymphomatoid granulomatosis with increased uptake of [18F] fluorodeoxyglucose in positron emission tomography: a case report.
Arai H; Oshiro H; Yamanaka S; Yukawa N; Wada N; Rino Y; Watanuki Y; Yamanaka S; Inayama Y; Lee J; Nakayama H; Masuda M
J Clin Exp Hematop; 2009 May; 49(1):39-44. PubMed ID: 19474516
[TBL] [Abstract][Full Text] [Related]
17. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
[TBL] [Abstract][Full Text] [Related]
18. A case of lymphomatoid granulomatosis mimicking sarcoidosis.
Fitch PS; Smith ME; Davies MG; Prentice AG
Respir Med; 1998 Jul; 92(7):966-8. PubMed ID: 10070572
[No Abstract] [Full Text] [Related]
19. Pitfall of
Tung K; Rosenthal AC; Craig FE; Ashman JB; Yang M
J Nucl Med Technol; 2018 Dec; 46(4):396-397. PubMed ID: 29884684
[TBL] [Abstract][Full Text] [Related]
20. Lymphomatoid granulomatosis. A case for aggressive therapy.
Jenkins TR; Zaloznik AJ
Cancer; 1989 Sep; 64(6):1362-5. PubMed ID: 2475241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
